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Abstract
Background: One means of treating osteoarthritis is with autologous or allogeneic osteochondral
grafts. The purpose of this study was to evaluate the innate immunological response in humans
toward xeno-derived osteochondral grafts that have been partially or entirely treated by the
photooxidation process.
Methods: The antigens tested included bovine, porcine, ovine and equine osteochondral samples
that have been treated in successive steps of photooxidation. ELISPOT assays were used to
evaluate the production of IL-1, IL-4, IL-6, IL-10, IL-12 and TNF-α  by human monocytes in response
to the antigens.
Results: Results indicated vigorous production of IL-1, IL-6, IL-10 and TNF-α  in response to
untreated bovine, porcine and equine specimens. This indicates that these samples are perceived
as foreign, or stimulatory, by the human monocytes. There was no induction of IL-4 or IL-12, which
is required for Th2 and Th1 immunity, respectively. In contrast, the processed bovine, porcine and
equine samples did not induce significant activation of cells of the innate immune system. This
occurred after the first step in processing (after cleaning in increasing strengths of ethanol). This
suggests that the processing steps dramatically, if not completely, negated the immunostimulatory
properties of the test sample. The results for the ovine samples indicate a reverse response.
Conclusion: The findings of the study suggest that photooxidized bovine, porcine or equine
samples have the potential to be used as an osteochondral graft. Although the first step in
processing reduced the immunological response, photooxidation is still necessary to retain the
structure and mechanical integrity of the cartilage, which would allow for immediate joint
resurfacing.
Background
There are various methods for repairing cartilage defects
in patients with osteoarthritis or other degenerative joint
disease. One such method is mosaicplasty, which consists
of the use of osteochondral grafting with autogenous [1-
3] or allogeneic [4-6] implants. Concerns exist, however,
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with the use of both autogenous grafts due to the need to
harvest the osteochondral implants from a joint or part of
a joint that is otherwise healthy, and for allogeneic mate-
rials with respect to disease transmission. Both of these
graft types also have a limited availability.
There is the potential for using photooxidized xenogeneic
osteochondral scaffolds in place of autogenous or alloge-
neic grafts. Photooxidation is a light-mediated process
that results in the cross-linking of collagen fibers. The
result is a material that is relatively non-immunogenic
and resistant to chemical and enzymatic degradation,
while maintaining the mechanical properties of the tissue,
as demonstrated with bovine [7-10] and porcine [11,12]
tissue. The photooxidized cartilage has been shown to
have no viable chondrocytes after treatment. [10]
Animal studies have included analysis of photooxidized
bovine pericardial tissue for replacement of the mitral
valve [13] and aortic valve. [14] In addition, the benefits
of photooxidation in vein grafting have been demon-
strated. [15,16] Additional animal studies have demon-
strated good biocompatibility with integration of xeno-
derived osteochondral scaffolds. [10,17,18] Kawalec et al.
[17] examined the use of photooxidized bovine osteo-
chondral plugs in a rabbit model. The grafts were
implanted into the patellar groove of both knees for 12
weeks. Histology indicated a chronic inflammatory reac-
tion to the photooxidized implant. Active bone remode-
ling was observed in the bone portion of the implant,
while the cartilage layer remained intact and undamaged,
but covered by a thin layer of fibrous tissue. Akens et al.
[18] implanted photooxidized xenogeneic osteochondral
plugs into the femoral condyle of ovine knees and com-
pared the findings to untreated xenogeneic and autoge-
neic grafts after six, 12 and 18 months. Macroscopically,
results indicated that most grafts possessed a well-main-
tained cartilage surface at all time points. Histologically,
sections from all three experimental groups showed evi-
dence of cystic lesions at six months, in addition to evi-
dence of bone remodeling. The number of sections
containing cysts decreased at 12 months for the photoox-
idized samples, but remained high for the untreated xeno-
geneic and autogeneic samples. This was also observed at
18 months. Cartilage fusion between graft and host was
observed for the photooxidized implants, but not for the
untreated xenogeneic and autogeneic implants.
The purpose of this study was to evaluate the innate
immunological response in humans toward xeno-derived
osteochondral grafts that have been partially or entirely
treated by the photooxidation process. The long-term goal
of this research is to evaluate the potential for using pho-
tooxidized xeno-derived osteochondral grafts in the repair
of articular cartilage defects.
Methods
Antigen preparation
The grafts tested in this project were made from bovine,
porcine, ovine or equine bone and cartilage. Samples were
prepared by removing an osteochondral plug approxi-
mately 8 mm in diameter by 7 mm in length. After
retrieval, the samples were placed in a phosphate-buffered
saline (PBS) solution to prevent them from drying out
prior to processing. There were five groups of grafts, with
the exception of the equine grafts, of which there were two
groups, based on the specific steps performed during
processing, as described in Table 1. Samples from each
group were then frozen at -80°C, ground to a fine powder
averaging 2–5 µm and subsequently lyophilized and
packaged prior to testing. The antigens were dissolved in
water at a concentration of 1 mg/ml and were used for the
ELISPOT assays at 10 µg/ml.
Human PBMC donors
Peripheral blood mononuclear cells (PBMC) were
obtained from ten healthy donors that were 30–50 years
of age, and ten donors that were 50–70 years of age. There
was an equal distribution of males and females.
Heparinized blood was obtained by venipuncture. The
study was performed under the approval of the Institu-
tional Review Board at the Ohio College of Podiatric
Medicine.
Table 1: Experimental groups. Five groups of antigens, based on specific steps performed during processing
Processing steps Bovine Group Porcine Group Ovine Group Equine Group
Group 1 – untreated B1 P1 O1 E1
Group 2 – after cleaning in increasing strengths of ethanol B2 P2 O2 N/A
Group 3 – after cleaning in ethanol and methylene chloride B3 P3 O3 N/A
Group 4 – after photooxidation process B4 P4 O4 N/A
Group 5 – after sterilization with Gamma radiation B5 P5 O5 E5BMC Musculoskeletal Disorders 2005, 6:36 http://www.biomedcentral.com/1471-2474/6/36
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Cell separations
The monocytes were isolated from PBMC by negative
selection using the RosetteSep enrichment cocktail (Stem-
cell Technologies, Vancouver, BC, Canada). The enrich-
ment cocktail was mixed with the blood to constitute a 50
µg/ml final concentration, followed by 20 minutes incu-
bation at room temperature. Subsequently, the cells were
separated using standard Ficoll-Hypaque density gradient
centrifugation. The ensuing isolated monocyte enriched
cell fraction was of >92% purity.
ELISPOT assays
Human cytokine ELISPOT assays for the detection of
Interleukin-1 (IL-1), IL-4, IL-6, IL-10, IL-12 and Tumor
Necrosis Factor-alpha (TNF-α ) were performed as
described previously [19]. Briefly, ImmunoSpot plates
(Cellular Technology Limited, Cleveland, OH) were
coated overnight at 4°C with the cytokine-specific capture
antibody in PBS at concentrations specified below. The
plates were blocked with 1% bovine serum albumin (10
g/l in PBS: PBS-BSA) for one hour and washed three times
with PBS. Monocytes were plated in triplicates in com-
plete RPMI 1640 medium at 5 × 104 cells per well. Anti-
gens were added at 10 µg/ml to the final concentration.
Wells containing the cells in the complete medium were
used as a negative control. For the bovine and porcine
samples tested with blood from the 30–50 year old age
group, lipopolysaccharide (LPS) at a concentration of 2
µg/ml was used as a positive control. For all other assays,
phytohemaglutinin (PHA) stimulation at a final concen-
tration of 10 µg/ml was used as a positive control.
The cells were cultured in an incubator at 37°C. The IL-1,
IL-4, IL-6 and TNF-α  assays cultured for 24 hours, while
the IL-10 and IL-12 assays were harvested after 48 hours.
Subsequently, the plates were washed three times with
PBS, then three times with PBS-Tween (0.5 %), and the
detection antibodies (in PBS-1% BSA-0.05%Tween) were
added at concentrations specified below. After an over-
night incubation at 4°C, plates were washed four times
with PBS-Tween, and the Streptavidin-Horse Radish Per-
oxidase (HRP) conjugate (Dako Corp., Carpenteria, CA)
was added at a 1:2000 dilution in PBS-BSA for 2 hours at
room temperature. Afterwards, plates were washed three
times with PBS-Tween followed by washing three times
with PBS.
The spots were visualized using the HRP-substrate 3-
amino-9-ethylcarbazole (AEC) (Pierce Pharmaceuticals,
Rockford, IL). The AEC stock solution was prepared by
dissolving 10 mg AEC in 1 ml N,N-dimethyl formamide
(Fisher Scientific, Fair Lawn, NJ). For the actual develop-
ment, 1 ml of the AEC stock solution was freshly diluted
into 30 ml of 0.1 M sodium-acetate buffer (pH 5.0), fil-
tered (0.45 µm), and mixed with 15 µl H2O2. Two hun-
dred µl of the AEC solution were plated per well. The
reaction was stopped by rinsing with distilled water when
spots became clearly visible macroscopically (10 to 45
minutes, dependent on the cytokine). The plates were air-
dried overnight before subjecting them to image analysis
using a Series 2 ImmunoSpot Analyzer (Cellular Technol-
ogy, Ltd., Cleveland, OH). Each measurement was made
in triplicate, and averaged to obtain the final value.
For human ELISPOT assays, the anti- IL-4, IL-6, IL-10, IL-
12 and TNF-α  antibodies that were used were purchased
from BD Pharmingen (San Diego, CA), while anti-IL-1
antibodies were received from Pierce Biotechnology
(Rockford, IL). Capture antibodies were used as follows:
anti-IL-1(cat. #M-421B-E) at 3 µg/ml, IL-4 (cat. #554515)
at 5 µg/ml, IL-6 (cat. #554543) at 1.5 µg/ml, IL-10 (cat.
#554705) at 5 µg/ml, IL-12 (cat. #555065) at 5 µg/ml,
and TNF-α  at 2 µg/ml (cat. #551220). For detection, bioti-
nylated antibodies were used: IL-1 (cat. #M-420B-E) at 0.3
µg/ml, IL-4 (cat. #554483) at 1.5 µg/ml, IL-6 (cat.
#554546) at 1 µg/ml, IL-10 (cat. #554499) at 1 µg/ml, IL-
12 (cat. #554660) at 0.6µg/ml, and TNF-α  at 1 µg/ml (cat.
#554511).
Results
Bovine samples
A representative photograph of individual ELISA spot
wells is shown in Figure 1. Each black spot represents a
cytokine-producing cell.
The results of the ELISA spot testing for bovine samples
tested with cells from donors 30–50 years of age are
shown in Figure 2. Untreated samples of bovine bone and
cartilage (group B1) induced vigorous production of IL-1,
IL-6, IL-10 and TNF-α ; however no induction of IL-4 or IL-
12 was seen. In contrast, the processed bone and cartilage
(groups B2–B5) did not induce significant activation of
cells of the innate immune system. The elevated levels of
IL-6 seen in all five groups were at a level similar to that
found in the media alone. For the positive controls, stim-
ulation with LPS resulted in a response on the order of
that seen with group B1.
The results of the ELISA spot testing for bovine samples
tested with cells from donors 50–70 years of age are
shown in Figure 3. The findings were very similar to that
produced by the 30–50 year old group. The exception was
the decreased production of IL-1 and IL-6 in response to
untreated samples of bone and cartilage (group B1). For
the positive control, stimulation with PHA resulted in
cells producing IL-1 and IL-6 too numerous to count,
while the number of cells producing IL-10 and TNF-α
were on the order of that produced by group B1.BMC Musculoskeletal Disorders 2005, 6:36 http://www.biomedcentral.com/1471-2474/6/36
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Porcine samples
The cytokine signature produced by testing porcine sam-
ples with cells from the 30–50 year old group (Figure 4) is
similar to the findings from the bovine samples tested
with cells from the same age group. In response to the
untreated porcine bone and cartilage (group P1), there
was a vigorous production of IL-1, IL-6, IL-10 and TNF-α ,
while no induction of IL-4 or IL-12 was seen. As with the
bovine samples, the processed specimens (groups P2–P5)
did not induce the significant response seen with the
untreated samples. For the positive control, stimulation
with LPS resulted in a response on the order of that seen
with group P1.
The results for the porcine samples tested with cells from
the individuals that were 50–70 years of age (Figure 5)
were similar to those from the bovine samples tested with
cells from the same group. A strong response was evoked
towards the untreated specimens (group P1), with respect
to IL-10 and TNF-α . While less than that produced by the
ELISA spot wells Figure 1
ELISA spot wells. Representative photograph of individual ELISA spot wells. Each black spot represents a cytokine-producing 
cell. This example represents IL-10 production by PBMC of healthy donors.BMC Musculoskeletal Disorders 2005, 6:36 http://www.biomedcentral.com/1471-2474/6/36
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Bovine 30–50 years old Figure 2
Bovine 30–50 years old. Production of cytokines by purified PBMC of healthy donors from 30–50 years old group (bovine).
Bovine 50–70 years old Figure 3
Bovine 50–70 years old. Production of cytokines by purified PBMC of healthy donors from 50–70 years old group (bovine).
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younger age group, the production of IL-1 and IL-6 was
still significant. As with the bovine results, the processed
specimens (groups P2–P5) did not induce a vigorous
response. For the positive controls, stimulation with PHA
resulted in cells producing IL-1 and IL-6 too numerous to
count, while the number of cells producing IL-10 and
TNF-α  were on the order of that produced by group P1.
Ovine samples
The results for the ovine samples tested with cells from the
30–50 year old group (Figure 6) were the reverse of those
from the bovine and porcine samples. Unprocessed sam-
ples (group O1) did not induce production of cytokines.
Only after sterilization with Gamma radiation (Group
O5) was there a slight increase in the production of IL-1
and IL-6. The production of IL-10 was much weaker than
that resulting from bovine and porcine samples. For the
positive controls, stimulation with PHA resulted in an
average number of cells producing IL-1 and IL-6 too
numerous to count, while the average number of cells
producing IL-10 and TNF-α  was also elevated in compari-
son to the negative control and experimental groups.
The cytokine signature for ovine samples tested with cells
from the 50–70 years of age group (Figure 7) was similar
to that from the younger age group. There was no cytokine
response to the untreated samples (group O1). After the
photooxidized process (group O4), there was an increase
in production of IL-1 and a vigorous production of IL-6
and TNF-α . After sterilization with Gamma radiation
(group O5), there was an even more vigorous production
of IL-6 and TNF-α . Again, the production of IL-10 was
much weaker than that observed with bovine and porcine
samples. For the positive controls, stimulation with PHA
resulted in elevated responses for IL-1, IL-6, IL-10 and
TNF-α , with respect to the negative control and experi-
mental groups.
Equine samples
Only two equine samples were tested: untreated speci-
mens (group E1) and after Gamma radiation (group E5).
The results for the equine samples tested with cells from
the 30–50 year old age group are shown in Figure 8. In
response to the untreated samples, there was a slight
increase in the production of IL-1, IL-6 and TNF-α . This
response was absent after sterilization with Gamma radi-
ation. There was no production of IL-10 for either group.
For the positive controls, stimulation with PHA resulted
in cells producing IL-1 and IL-6 too numerous to count.
The number of cells producing IL-10 was two orders of
magnitude greater than group H1 and those producing
Porcine 30–50 years old Figure 4
Porcine 30–50 years old. Production of cytokines by purified PBMC of healthy donors from 30–50 years old group 
(porcine).
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TNF-α  was one magnitude of order greater than that pro-
duced by group H1.
The cytokine signature for equine samples tested with
cells from the older age group (Figure 9) was similar to
that from the younger age group. In response to untreated
samples, there was production of IL-1, IL-6 and TNF-α .
This response did not appear after sterilization with
Gamma radiation. It should be noted that there was an
absence in the production of IL-10 for both groups. For
the positive controls, stimulation with PHA resulted in
elevated responses for IL-1, IL-6, IL-10 and TNF-α , with
respect to the negative control and experimental groups.
Discussion
The cytokine signature produced by the untreated bovine
and porcine samples is consistent with vigorous activation
of cells of the innate immune system. This pertains prima-
rily to cytokines involved in induction of a humoral
immune response (IL-10), but not of cytokines that are
required for Th1 immunity (IL-12) or Th2 immunity (IL-
4). The IL-1 and TNF-α  production seem to favor mixed
Th0-type T cell responses. This indicates that the untreated
bovine and porcine samples are perceived as foreign, or
stimulatory, by the human cells. This is consistent in both
age groups, and most individuals tested behaved compa-
rably. Therefore, in spite of genetic differences in the
human test population, rather uniform response patterns
were seen, suggesting that the findings will broadly apply
to the human population.
In contrast, the processed bovine and porcine osteochon-
dral samples did not induce the production of cytokines.
This was observed after the first processing step, after
cleaning in increasing strengths of ethanol. This suggests a
highly improved biocompatibility, with respect to induc-
ing a rejection T cell/antibody response and inducing ster-
ile granulomatous rejections in the sense of a foreign body
reaction. It can be expected that these non-stimulatory
samples can be considered well suited for transplantation.
Again, this was observed for both age groups.
The cytokine signature for equine samples tested with
cells from both age groups is similar to that observed with
bovine and porcine samples. The exception with the
untreated samples is the weak production of IL-10, which
is a potent B cell differentiation factor. Thus, the equine
samples may be less likely to induce antibody responses.
The reverse was seen in response to ovine samples. The
untreated samples did not produce a response, while the
specimens that were photooxidized, and to a greater
extent those that were sterilized with Gamma irradiation
resulted in a response of IL-1, IL-6 and TNF-α . This sug-
Porcine 50–70 years old Figure 5
Porcine 50–70 years old. Production of cytokines by purified PBMC of healthy donors from 50–70 years old group 
(porcine).
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gests a mixed Th0-type T cell response. There was a much
weaker production of IL-10, which indicates the absence
of a humoral response. These findings were observed with
both age groups.
It should be noted that the graft material tested in this
study was a prepared material that was subjected to a
series of proprietary steps of cleaning, photooxidation
and sterilization in order to develop a graft or scaffold that
avoids human antigenicity and rejection reactions. The
antigenic composition of the processed material (groups
2–5) is fundamentally different from the natural, unproc-
essed material (group 1). It was intended to test each graft
as a whole, as it is proposed to be used in clinical applica-
tions, rather than breaking down the graft into its compo-
nents. The grafts that have been photooxidized are not live
material, and have been rendered hypo-immunogenic to
an extent that they are accepted in a series of recipient ani-
mal species without the need for immune suppression.
[10,17,18] Photooxidized materials have been used clini-
cally in cardiac surgery, and, to the best of our knowledge,
with the graft material tested as a whole and not its poten-
tial constituents. [11-16]
Previous work has established that photooxidized carti-
lage is accepted by the host better than untreated cartilage.
[17,18] It is likely that the oxidation process chemically
modifies the protein components in such a way that these
structures stimulate cells of the innate immune system to
induce, for example, prostaglandins. Frequently, sterile
inflammation of this sort enhances wound repair and
therefore enhances the vascularization and integration of
the grafted tissue, rather than rejection. Because the clini-
cal acceptance of these grafts is common we assume that
such reactions are also induced in this model.
Monocytes are not constitutive parts of the joint, however
these cells are rapidly recruited to the joint after tissue
injury, including surgical implantation of grafts. Unlike
chondrocytes that are not professional antigen presenting
cells, monocytes can phagocytose, process and present
graft antigens and initiate an immune response. This ini-
tial phase was evaluated in this study. Once the T cells are
primed, they can interact with chondrocytes and other
non-professional antigen presenting cells in the joint to
exert the effector arm of the rejection reaction.
Ovine 30–50 years old Figure 6
Ovine 30–50 years old. Production of cytokines by purified PBMC of healthy donors from 30–50 years old group (ovine).
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Ovine 50–70 years old Figure 7
Ovine 50–70 years old. Production of cytokines by purified PBMC of healthy donors from 50–70 years old group (ovine).
Equine 30–50 years old Figure 8
Equine 30–50 years old. Production of cytokines by purified PBMC of healthy donors from 30–50 years old group (equine).
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The conclusions reached in this study were drawn using in
vitro experiments. The isolation of monocytes and their
tissue culture plates might affect the functionality of the
cells and modify them relative to their in vivo activation
state. These constraints apply to any in vitro work. How-
ever, the purpose of this study was to establish whether
monitoring the activity of such cells in vitro would
provide insights on additional activation of them by stim-
ulation with compounds such as the tissue culture mate-
rial that was used. It is clearly shown that beyond
whatever activation occurs in tissue culture, the graft
materials tested induce a variable level of activation.
Because activation of such cells of the innate immune sys-
tem is key to their immunological activity, this study
shows that sensitive monitoring of monocytes activity in
response to such materials can be done in vitro.
Conclusion
Grafts are rejected by a series of immune recognition
events that include cells of the innate immune system
(dendritic cells, macrophages) as well as the downstream
activation of lymphocytes. Activation of cells of the innate
immune system is a prerequisite for inducing an immune
response by lymphocytes. Moreover, the type of cytokines
induced in cells of the innate immune system by the anti-
gen will define the (Th1/Th2) type of T cell response that
evolves. This study demonstrated a reduction in the innate
immune response to processed bovine, porcine and
equine bone and cartilage, indicating a potential for use as
a xeno-derived osteochondral scaffold. The effect was
observed to occur after the first step in processing (after
cleaning with increasing strengths of alcohol).
Although the first step in processing reduced the immuno-
logical response, photooxidation is still necessary to
retain the structure and mechanical integrity of the carti-
lage, which would then allow for immediate joint resur-
facing. The next phase of the study is to evaluate the
downstream activation of the immune system caused by
xeno-derived osteochondral grafts in an active system
model, using an animal model. This will be followed by
evaluation of the implant and immune reactions when a
photooxidized implant is placed in the joint environ-
ment. Subsequent evaluation for the detection of viral or
other residual infectious materials, such as α -galactase, is
needed to alleviate concerns about xenotransplantation.
Equine 50–70 years old Figure 9
Equine 50–70 years old. Production of cytokines by purified PBMC of healthy donors from 50–70 years old group (equine).
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